Webinar: Dr. Serge Verstovsek and Prof. Haifa Al-Ali talking about the POIESIS Trial Insights
- Peter Löffelhardt
- 4 days ago
- 1 min read
The Global MPN Scientific Foundation is proud to host its second exclusive webinar, titled "Unlocking the Future of MPNs: POIESIS Trial Insights". This key event will provide the latest information on the groundbreaking POIESIS clinical trial, a cutting-edge study focused on new treatment mechanisms for Myeloproliferative Neoplasms (MPNs).
🗓 Date: Monday, September 8th, 2025
🕕 Time: 6:00 PM – 7:00 PM (CEST)
📍 Online (Zoom)
For the convenience of our diverse audience, this live session will offer simultaneous translation into Spanish.
Content guide
Meet the Expert Speakers
We are honored to have two leading experts present at this event:
Dr. Serge Verstovsek: A world-renowned physician-scientist and a leading authority in the field of Myeloproliferative Neoplasms. With over 100 clinical trials and 700+ publications, Dr. Verstovsek will explain the science behind this innovative approach and what it could mean for patients worldwide.
Prof. Haifa Al-Ali: A distinguished hematologist and oncologist at the University Hospital of Halle (Germany), Prof. Al-Ali will share her clinical expertise and provide valuable insights into the ongoing research.
About the POIESIS Trial
Developed by Karthos Therapeutics, the POIESIS trial is a significant international study. It explores new mechanisms of action to treat MPNs, specifically focusing on Myelofibrosis. The research aims to improve patient outcomes and quality of life by activating the P53 pathway.
This is an essential session for anyone interested in the future of MPN research, including patients, caregivers, and healthcare professionals.
Comments